137 related articles for article (PubMed ID: 8456522)
21. [Treatment onychomycoses--bifonazole nail set in comparison with urea with ciclopiroxolamine formulation].
Rüping KW; Haas PJ
Z Arztl Fortbild (Jena); 1993 Apr; 87(5):425-9. PubMed ID: 8322470
[No Abstract] [Full Text] [Related]
22. Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum.
Ceschin-Roques CG; Hänel H; Pruja-Bougaret SM; Lagarde I; Vandermander J; Michel G
Skin Pharmacol; 1991; 4(2):95-9. PubMed ID: 1878248
[TBL] [Abstract][Full Text] [Related]
23. New Topical Therapeutic Options in the Management of Superficial Fungal Infections.
Zeichner JA
J Drugs Dermatol; 2015 Oct; 14(10 Suppl):s35-41. PubMed ID: 26461833
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous phaeohyphomycosis caused by Pyrenochaeta unguis-hominis in a diabetic patient: A case report.
Gong Y; Chen Z; Ma Y; Jiang W; Hu Y; Shi Y
Australas J Dermatol; 2020 May; 61(2):e221-e222. PubMed ID: 31724160
[TBL] [Abstract][Full Text] [Related]
25. A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).
Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):suppl 1 p.. PubMed ID: 16518906
[No Abstract] [Full Text] [Related]
26. Lamisil -- A New Measure in Antifungal Therapy in Skin and Nail Disease. Proceedings of a symposium. Vienna, Austria, 18 May 1993.
Br J Dermatol; 1994 Apr; 130 Suppl 43():1-44. PubMed ID: 7910478
[No Abstract] [Full Text] [Related]
27. Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails.
Neubert RH; Gensbügel C; Jäckel A; Wartewig S
Pharmazie; 2006 Jul; 61(7):604-7. PubMed ID: 16889067
[TBL] [Abstract][Full Text] [Related]
28. Transungual drug delivery: current status.
Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of the topical antimycotic treatment in psoriatic onychopathy with severe perionychia].
Santagostino L; Giorgetti P; Di Cintio R; Albanese G
G Ital Dermatol Venereol; 1988 May; 123(5):253-9. PubMed ID: 3209245
[No Abstract] [Full Text] [Related]
30. [Green-black discoloration of the nails?].
Abeck D
Med Monatsschr Pharm; 2007 Dec; 30(12):461. PubMed ID: 18196849
[No Abstract] [Full Text] [Related]
31. [An open clinico-mycologic study on the efficiency and tolerability of ciclopiroxolamine].
Lasagni A; Oriani A; Terragni L
G Ital Dermatol Venereol; 1986; 121(2):XXIX-XXXII. PubMed ID: 3710527
[No Abstract] [Full Text] [Related]
32. Fungal melanonychia and Exophiala dermatitidis.
Lo Schiavo A; Gambardella A; Caccavale S
Mycoses; 2013 Mar; 56(2):187-8. PubMed ID: 22676703
[No Abstract] [Full Text] [Related]
33. [Treatment of dermatomycoses with ciclopiroxolamine].
Szepes E; Schneider I
Mykosen; 1986 Aug; 29(8):382-6. PubMed ID: 3762592
[No Abstract] [Full Text] [Related]
34. [Fungal and bacterial nail infections].
Feuilhade de Chauvin M
Rev Prat; 2000 Dec; 50(20):2223-30. PubMed ID: 11217123
[TBL] [Abstract][Full Text] [Related]
35. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
[TBL] [Abstract][Full Text] [Related]
36. [Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
Fredriksson T; Savopoulos C
Arzneimittelforschung; 1981; 31(8A):1376-8. PubMed ID: 7028050
[TBL] [Abstract][Full Text] [Related]
37. [Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)].
Torres J; Savopoulos C; Dittmar W
Arzneimittelforschung; 1981; 31(8A):1373-6. PubMed ID: 7028049
[TBL] [Abstract][Full Text] [Related]
38. [Use of Phytex for mycoses of the skin].
Ogawa Y; Yamada M; Ishibashi M; Wakai Y
Acta Dermatol Kyoto Engl Ed; 1967 May; 62(2):138-42. PubMed ID: 5630437
[No Abstract] [Full Text] [Related]
39. Ciclopirox: an overview.
Gupta AK
Int J Dermatol; 2001 May; 40(5):305-10. PubMed ID: 11554991
[No Abstract] [Full Text] [Related]
40. [Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
Adam W; Peil HG; Savopoulos C; Vanderbeke O
Arzneimittelforschung; 1981; 31(8A):1360-5. PubMed ID: 7028047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
